Whats new at rapidrapidai? RapidAI acquires Endovantage, an innovator in comprehensive aneurysm management—expanding scope from stroke to aneurysm. RapidAI Insights launches—offering a suite of reports and analytics on Rapid scan, treatment, and outcomes data.What is rapidai powered rapid aspects? AI-powered Rapid ASPECTS becomes the first ever neuroimaging solution to receive FDA clearance in the CADx (Computer-Assisted Diagnostic software) category. RapidAI hits a major milestone with over 1 million recorded scans and is used in 1,600+ hospitals worldwide.What can physphysicians do with rapidai? Physicians can save precious time with anywhere, anytime notifications of new patient cases and access to RapidAI results and compressed patient images on their mobile device. RapidAI is the most widely used imaging software among physicians for stroke patient care, research, and clinical trials.How many clinical trials have been conducted with rapidai? Since then, RapidAI technology has been validated in more than a dozen multicenter clinical trials. (The recommended treatment window has since been extended to 24 hours.) Rapid CTP developed and installed in more than 70 North American and European sites for the SWIFT PRIME, EXTEND, and EXTEND-IA trials.
Unfortunately, this phone number cannot accept voice calls or can be used as a support channel for questions unrelated to an active delivery. Still, have questions? Feel free to email us at [email protected] or submit a new ticket at Support Portal. This is a monitored channel by Rapidus Support Team and you will get a quick response.